.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In July 2026, Orchid CBD concentrated 37.09% of sales in Vapor Pens and 35.70% in Pre-Roll, with Flower at 27.20%, indicating a tight two-category split at the top and a meaningful third pillar. Vapor Pens rose 25.63% month over month and 20.73% year over year, while Pre-Roll climbed 24.09% MoM and 27.50% YoY; Flower delivered a smaller 3.54% MoM increase but a 58.23% YoY jump, suggesting mix broadening rather than a single-category surge. With overall brand sales up 31.72% year over year and the average price down 5.51% YoY to $27.88, the combination of double-digit MoM lifts in Vapor Pens and Pre-Roll alongside outsized YoY gains in Flower implies price-enabled volume expansion and a more balanced portfolio that can absorb category volatility.
These shifts reposition Orchid CBD toward a price-to-volume play anchored by two near-equal lead categories and reinforced by a faster-growing Flower base, which reduces reliance on any one format and cushions seasonal swings. The 37.09% share in Vapor Pens versus 35.70% in Pre-Roll, combined with a 58.23% YoY increase in Flower against only a 3.54% MoM change, indicates that short-term momentum comes from inhalables while longer-cycle growth compounds in Flower; in Ontario Pre-Roll ranking at 79 suggests headroom if the MoM Pre-Roll growth rate of 24.09% can be sustained alongside the 25.63% MoM in Vapor Pens, pointing to a positioning that prioritizes velocity at accessible pricing rather than premium-tier depth.
Competitive Landscape
Orchid CBD sits at rank #79 in ON Pre-Roll for July 2026, improving 12 positions year over year from #91 while also edging up 6 spots from April 2026’s #85; this is its peak rank to date at #79 in July 2026. In contrast, Back Forty / Back 40 Cannabis advanced from #2 to #1 with a 67.4% YoY sales lift, and General Admission slipped from #1 to #2 alongside a 23.2% YoY sales decline, positioning Orchid CBD’s upward drift as a share-capture opportunity from incumbents losing ground and a signal that incremental gains can compound if sustained against fast-rising players like Spinach climbing from #14 to #5 with 65.3% YoY growth.
Notable Products
CBD Jean Guy Pre-Roll 5-Pack (2.5g) posted the largest month-over-month move at +645.3% to enter July 2026 in rank 7, while CBD Jean Guy (3.5g) surged +129.5% to rank 6, together signaling a rapid shift of demand toward the Jean Guy line. In contrast, CBD:THC 1:1 Runtz (3.5g) fell -53.0% to rank 10 as CBD:THC 2:1 Runtz (3.5g) slipped -9.0% to rank 3, indicating that balanced Runtz flower ceded share even as the CBD Runtz Live Resin Cartridge (1g) held rank 1 with +25.6% MoM. Four of the top ten are Pre-Roll SKUs with two Runtz multi-pack formats at ranks 2 and 8 growing +26.1% and +23.9%, concentrating momentum in ready-to-consume formats and away from mixed-ratio flower. The pattern implies Orchid CBD is tilting toward convenience-led inhalables anchored by flavored Runtz vapes and fast-rising Jean Guy pre-rolls, suggesting portfolio weight should continue shifting from balanced flower into Pre-Roll and Vapor Pens.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
